Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy

Area of Science:

• Cardiology
• Cell Biology
• Metabolic Diseases

Background:

• Diabetic cardiomyopathy (DC) is a complication of diabetes mellitus (DM) leading to heart failure (HF).
• Ferroptosis, a cell death pathway marked by oxidative stress and lipid peroxidation, is increasingly implicated in DC pathogenesis.
• Direct evidence for DC and its specific mechanisms remain areas of active investigation.

Purpose of the Study:

• To systematically review the pathogenic mechanisms linking ferroptosis to diabetic cardiomyopathy.
• To elucidate the molecular pathways involved in ferroptosis-induced cardiac dysfunction in the context of DM.

Main Methods:

• Review of existing cell and animal studies on ferroptosis and DC.
• Analysis of molecular mechanisms including retinol metabolism, CD36, Nrf2, and lncRNA-ZFAS1 interactions.

Main Results:

• Reduced cardiac RDH10, mediated by retinol metabolism disorders, induces ferroptosis in DC.
• CD36 overexpression leads to lipid deposition and decreased GPX4, promoting ferroptosis in DC cardiomyocytes.
• Nrf2 activation promotes iron overload and lipid peroxidation, exacerbating ferroptosis in DC.
• The lncRNA-ZFAS1/miR-150-5p/CCND2 axis triggers ferroptosis in DC.

Conclusions:

• Ferroptosis is a key mechanism driving diabetic cardiomyopathy progression.
• Targeting ferroptosis pathways presents a potential therapeutic strategy for managing DC and preventing heart failure.